Search
Advertisement
neetu chandra sharma
Neetu Chandra Sharma

Neetu Chandra Sharma

TVTN

neetu.chandra@aajtak.com

Neetu Chandra Sharma is a Senior Editor at Business Today, where she leads the magazine’s coverage of healthcare and pharmaceuticals. With over two decades of experience in top Indian newsrooms—including Mint, Hindustan Times, the India Today Group, ...

SHOW MORE...

Follow Neetu Chandra Sharma on:

Rainbow Children’s Q2 Revenue Rises 23% As Patient Volumes And Hospital Network Expand

Rainbow Children’s Q2 Revenue Rises 23% As Patient Volumes And Hospital Network Expand

by Neetu Chandra Sharma |Nov 3, 2026

Rainbow Children’s Medicare Limited reported 23% year-on-year revenue growth to ₹548 crore in Q2 FY27, while EBITDA rose 14% and profit after tax increased 11%. Inpatient discharges grew 15%, outpatie...

Sun Pharma Q2 Sales Rise 11.8% To ₹16,100 Crore; India Grows 17.3%, US Sales Decline 8.2%

Sun Pharma Q2 Sales Rise 11.8% To ₹16,100 Crore; India Grows 17.3%, US Sales Decline 8.2%

by Neetu Chandra Sharma |Nov 2, 2026

Sun Pharmaceutical Industries reported 11.8% year-on-year growth in sales to ₹16,100 crore in Q2 FY27. Adjusted net profit stood at ₹3,162 crore, while reported net profit was ₹1,988.5 crore. EBITDA i...

Shweta Rai of Bayer Pharmaceuticals is looking to expand the portfolio

by Neetu Chandra Sharma |Oct 29, 2026

The Bayer Pharmaceuticals India chief is looking to expand the portfolio and strengthen the country’s contribution to global drug development.

Piramal Pharma Q2 Profit At ₹5 Crore After Year-Ago Loss; FY27 Growth Outlook Raised

Piramal Pharma Q2 Profit At ₹5 Crore After Year-Ago Loss; FY27 Growth Outlook Raised

by Neetu Chandra Sharma |Oct 28, 2026

Piramal Pharma reported a consolidated net profit of ₹5 crore in Q2 FY27, compared with a loss of ₹99 crore a year ago, as revenue rose 28% to ₹2,617 crore and EBITDA jumped 72% to ₹385 crore. The com...

Syngene Q2 profit falls 52% to ₹32 crore as lower Zoetis revenue, forex losses hit margins

Syngene Q2 Profit Falls 52% To ₹32 Crore As Lower Zoetis Revenue, Forex Losses Hit Margins

by Neetu Chandra Sharma |Oct 28, 2026

Syngene International reported a 52% year-on-year decline in profit after exceptional items to ₹32 crore in Q2 FY27, while revenue fell 9% to ₹833 crore, primarily due to lower Zoetis revenues and for...

Alisha Moopen on expanding hospital capacity beyond 15,000 beds

Alisha Moopen on expanding hospital capacity beyond 15,000 beds

by Neetu Chandra Sharma |Oct 28, 2026

Alisha Moopen is overseeing four hospital businesses as Aster DM Quality Care seeks to raise capacity from over 10,800 to more than 15,000 beds.

Pfizer India’s Meenakshi Nevatia on making new therapies more accessible

Pfizer India’s Meenakshi Nevatia on making new therapies more accessible

by Neetu Chandra Sharma |Oct 28, 2026

Pfizer India’s Meenakshi Nevatia is focusing on new therapies, affordability and partnerships as she works to expand the business.

Soumya Chava on Laurus Labs’ push into finished-dose drugs

Soumya Chava on Laurus Labs’ push into finished-dose drugs

by Neetu Chandra Sharma |Oct 28, 2026

Soumya Chava of Laurus Labs is targeting growth in finished-dose drugs and contract manufacturing across global markets.

Alkem’s Madhurima Singh on scaling businesses and building stronger teams

Alkem’s Madhurima Singh on scaling businesses and building stronger teams

by Neetu Chandra Sharma |Oct 27, 2026

Madhurima Singh is backing new healthcare businesses, strengthening the pharmaceutical business, and building teams that can take on greater responsibility.

Nilima Prasad Divi on where Divi’s spends, invests, and expands

by Neetu Chandra Sharma |Oct 27, 2026

Nilima Prasad Divi is focusing on procurement, capital allocation, and operational preparedness as the company invests in capacity.